Administration of a single dose of long-acting injectable progesterone formulation reduces the stress response to weaning in anestrous ewes

被引:4
|
作者
Ungerfeld, R. [1 ]
Freitas-de-Melo, A. [1 ]
机构
[1] Univ Republica, Fac Vet, Dept Biociencias Vet, Ruta 8,Km 18, Montevideo 13000, Uruguay
关键词
Distress; Cortisol; Sheep; Welfare; Sex steroid; ALLOPREGNANOLONE; PREGNANCY; BRAIN; SHEEP; RAT; AGE;
D O I
10.1016/j.domaniend.2022.106753
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
High circulating progesterone concentrations decrease the responses to stressful situations in farm ruminants. We hypothesized that administering a single dose of long-acting pro-gesterone formulation reduces the stress response of anestrous ewes to weaning. The aim of this study was to compare the behavioral, cortisol, and blood protein responses to wean-ing of anestrous ewes treated or not, with a single dose of a long-acting progesterone for-mulation. A complementary aim was to characterize the bioavailability of progesterone af-ter this treatment. Thirty-six multiparous single-lambing Corriedale ewes and their lambs were used in this study. The lambs were weaned at 6:30 h when they were 65 d old (d0), and were taken to another paddock without chemical, visual or auditory contact with their mothers, while the ewes remained in the same paddock. Immediately before wean-ing, while 19 ewes received oil based long-acting progesterone formulation, other 17 ewes remained as controls, receiving sunflower oil. Twelve ewes from each group were used for behavioral recordings, the other 5 untreated ewes and 7 treated ewes were used to char-acterize the cortisol response and the progesterone profile. Behaviors were recorded every 10th min for 3 h in the morning and 3 h in the afternoon on day minus 3, d0 and d2, and expressed as percentage of recordings each animal displayed each behavior on each day. Treated ewes were recorded more times standing up than ewes on the day of weaning (P < 0.05), but the reverse result was found 2 d after (P < 0.01). Treated ewes were recorded more times lying down than control ewes on d2 after weaning (P < 0.0 0 01), when treated ewes were observed fewer times walking than control ewes (P = 0.0 0 04), as also happened the day of weaning (P < 0.0 0 01). On the day of weaning, treated ewes grazed and paced less than control ewes (P = 0.001 and P = 0.009). Treated ewes ruminated more than con-trol ewes on the day of weaning (P = 0.02) and 2 d later (P = 0.0 0 02). Control ewes also secreted more cortisol than progesterone-treated ewes (P = 0.03), with no effect of the treatment on the concentration of total proteins, albumin or globulins. While control ewes never had luteal progesterone concentrations ( >0.5 ng/mL), treated ewes achieved luteal progesterone concentrations 2 h after its administration, and remained well above luteal levels until 15 h after administration. The administration of a single dose of long-acting progesterone formulation appears to be a viable choice in reducing the stress to weaning in ewes. Ewes treated with progesterone coped better with weaning, returning to their nor-mal basal behavior earlier than untreated ones, and secreting lower cortisol levels.(c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页数:7
相关论文
共 35 条
  • [31] Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats
    Gedulin, BR
    Smith, P
    Prickett, KS
    Tryon, M
    Barnhill, S
    Reynolds, J
    Nielsen, LL
    Parkes, DG
    Young, AA
    DIABETOLOGIA, 2005, 48 (07) : 1380 - 1385
  • [32] RADIOIMMUNOASSAY OF [D-TRP6] LUTEINIZING-HORMONE-RELEASING HORMONE - ITS APPLICATION TO ANIMAL PHARMACOKINETIC STUDIES AFTER SINGLE INJECTION AND LONG-ACTING FORMULATION ADMINISTRATION
    EZAN, E
    DRIEU, K
    CHAPELAT, M
    ROUGEOT, C
    DRAY, F
    REGULATORY PEPTIDES, 1986, 14 (02) : 155 - 167
  • [33] GONADOTROPIN AND GONADAL-STEROID RESPONSE TO A SINGLE-DOSE OF A LONG-ACTING AGONIST OF GONADOTROPIN-RELEASING-HORMONE IN OVULATORY AND ANOVULATORY WOMEN WITH POLYCYSTIC-OVARY-SYNDROME
    WHITE, D
    LEIGH, A
    WILSON, C
    DONALDSON, A
    FRANKS, S
    CLINICAL ENDOCRINOLOGY, 1995, 42 (05) : 475 - 481
  • [34] Quantitative assessment of betamethasone dual-acting formulation in urine of patients with rheumatoid arthritis and ankylosing spondylitis after single-dose intramuscular administration and its application to long-term pharmacokinetic study
    Kopylov, Arthur T.
    Novikov, Alexander A.
    Kaysheva, Anna L.
    Vykhodets, Igor T.
    Karateev, Drnitry E.
    Zgoda, Victor G.
    Lisitsa, Andrey V.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 149 : 278 - 289
  • [35] A Double-Blinded, Placebo Controlled, Single Ascending Dose Study for Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics after Subcutaneous Administration of Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in Healthy Obese Subjects
    Choi, Jae Duk
    Baek, Seungjae
    Kim, Youngmin
    Eun, Kahee
    Kwon, Se Chang
    Morrow, Linda
    Hompesch, Marcus
    Kang, Jahoon
    DIABETES, 2019, 68